EUCTR2005-002765-37-IT进行中（未招募）不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDGPET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin,s lymphoma - H10 EORTC/GELA Randomized Intergroup Trial
EORTC Lymphoma Group0 个研究点目标入组 1,797 人开始时间: 2007年6月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,797
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Histologically confirmed Hodgkin`s lymphoma (HL), except for nodular lymphocyte predominant subtype (nodular paragranuloma); -Supradiaphragmatic Ann Arbor clinical stage I or II; -Previously untreated; - Clinical stages I/II; - Age 18-70 years; - WHO performance 0-3: - FDG-PET scan prospectively planned after two cycles of ABVD in all patients; - Informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 1774
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 20
排除标准
- •-Histologically not confirmed Hodgkin's lymphoma (HL), - lymphocyte predominant subtype (nodular paragranuloma:) - Previously treated; - Age <18 or >70 years - WHO performance >3 - Pregnat or breast-feeding women - HIV infection - Absence of Informed consent
研究者
相似试验
进行中（未招募）
不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Hodgkin’s lymphomaMedDRA version: 8.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseEUCTR2005-002765-37-NLEuopean Organisation of Research and Treatment of Cancer1,600
进行中（未招募）
不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Supradiaphragmatic stage I/II Hodgkin’s lymphomaMedDRA version: 14.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2005-002765-37-BEEuopean Organisation of Research and Treatment of Cancer1,797
进行中（未招募）
不适用
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Hodgkin’s lymphomaMedDRA version: 8.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseEUCTR2005-002765-37-DKEuopean Organisation of Research and Treatment of Cancer1,600
进行中（未招募）
1 期
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaptation versus standard combined modality treatment in patients with supradiaphragmatic stage I/II Hodgkin's lymphoma. - H10Hodgkin’s lymphomaMedDRA version: 8.1 Level: HLGT Classification code 10025319 Term: Lymphomas Hodgkin's diseaseEUCTR2005-002765-37-SKEuopean Organisation of Research and Treatment of Cancer1,950
尚未招募
3 期
The H10 EORTC/GELA randomized Intergroup trial on early FDG-PET scan guided treatment adaption versus standard combined modality treatment in patiënts with supradiaphragmatic stage I/II Hodgkin's lymphomaNL-OMON29848European Organisation for Research in Treatment of Cancer (EORTC)500